✦ LIBER ✦

442 Marked loss of LH bioactivity in men with cancer of the prostate treated with an LHRH agonist and an antiandrogen

✍ Scribed by R. St-Arnaud; S. Kelly; A. Dupont; A. Belanger; F. Labrie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LOSS OF LUTEINIZING HORMONE BIOACTIVITY

✍ R. ST-ARNAUD; R. LACHANCE; SUSAN J. KELLY; BELANGER. A. DUPONT; F. LABRIE 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

Pituitary desensitization and loss of lu

✍ R. St-Arnaud; R. Lachance; A. Bélanger; A. Dupont; F. Labrie 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 84 KB

New hormonal treatment in cancer of the

✍ F. Labrie; A. Dupont; A. Belanger; F.A. Lefebvre; L. Cusan; G. Monfette; J.-G. L 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 987 KB

441 Inhibitory effect of combined admini

✍ A. Belanger; A. Dupont; F. Labrie; J.P. Raynaud 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 98 KB

An open-label study of abarelix in men w

✍ Michael Koch; Christopher Steidle; Stanley Brosman; Arthur Centeno; Franklin Gay 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A randomized controlled trial of add-bac

✍ Rose H. Matousek; Barbara B. Sherwin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 497 KB